Investing.com -- Cognition Therapeutics Inc (NASDAQ: CGTX) stock surged 14% following the announcement of upcoming presentations of Phase 2 study results for its dementia with Lewy bodies (DLB) ...

Gabapentin, a common painkiller, may increase dementia risk with frequent use. Younger users are especially vulnerable.

Higher glycemia was associated with worse cognitive score outcomes among patients with short-duration type 2 diabetes at 4-year follow-up.

Discover Stephen Wolfram's insights on AI, human cognition, and the future of knowledge in a world where machines think ...

A recent study using brain scans of crew members at an Antarctic research station reveals significant changes in brain ...

Cognitions acquisition of Windsurf highlights the ongoing competition for AI talent among tech giants. Discover details of ...

The move is the culmination of a turbulent period for Windsurf, and indicates that agentic IDEs have become a new ...

Learn how Cognition and Windsurf are hoping to reshaping software development with AI agents that streamline workflows and ...

Goldman Sachs has introduced Devin, an AI software engineer developed by Cognition, marking a major shift in tech hiring.

The artificial intelligence dealmaking frenzy over the past few weeks is shifting Silicon Valley norms and creating wealth at ...

Cognition acquires Windsurf to integrate IDE with AI agent Devin, promoting synergy and innovation in AI-assisted coding.

A groundbreaking study reveals that red-footed tortoises experience long-term mood states. Researchers specializing in animal ...